217 related articles for article (PubMed ID: 7855175)
1. PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.
Karlsson P; Farde L; Halldin C; Swahn CG; Sedvall G; Foged C; Hansen KT; Skrumsager B
Psychopharmacology (Berl); 1993; 113(2):149-56. PubMed ID: 7855175
[TBL] [Abstract][Full Text] [Related]
2. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
Halldin C; Foged C; Chou YH; Karlsson P; Swahn CG; Sandell J; Sedvall G; Farde L
J Nucl Med; 1998 Dec; 39(12):2061-8. PubMed ID: 9867142
[TBL] [Abstract][Full Text] [Related]
3. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
[TBL] [Abstract][Full Text] [Related]
4. [11C]NNC 22-0215, a metabolically stable dopamine D1 radioligand for PET.
Foged C; Halldin C; Swahn CG; Ginovart N; Karlsson P; Lundkvist C; Farde L
Nucl Med Biol; 1998 Jul; 25(5):503-8. PubMed ID: 9720669
[TBL] [Abstract][Full Text] [Related]
5. 11C- and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PET.
Foged C; Halldin C; Loc'h C; Mazière B; Karlsson P; Mazière M; Swahn CG; Farde L
Nucl Med Biol; 1996 Aug; 23(6):837-44. PubMed ID: 8940728
[TBL] [Abstract][Full Text] [Related]
6. PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756.
Laihinen AO; Rinne JO; Ruottinen HM; Någren KA; Lehikoinen PK; Oikonen VJ; Ruotsalainen UH; Rinne UK
J Nucl Med; 1994 Dec; 35(12):1916-20. PubMed ID: 7989969
[TBL] [Abstract][Full Text] [Related]
7. [11C]NNC 687 and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey.
Halldin C; Foged C; Farde L; Karlsson P; Hansen K; Grønvald F; Swahn CG; Hall H; Sedvall G
Nucl Med Biol; 1993 Nov; 20(8):945-53. PubMed ID: 8298574
[TBL] [Abstract][Full Text] [Related]
8. 11C-SCH 39166, a selective ligand for visualization of dopamine-D1 receptor binding in the monkey brain using PET.
Sedvall G; Farde L; Barnett A; Hall H; Halldin C
Psychopharmacology (Berl); 1991; 103(2):150-3. PubMed ID: 1674157
[TBL] [Abstract][Full Text] [Related]
9. Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia.
Guo N; Hwang DR; Lo ES; Huang YY; Laruelle M; Abi-Dargham A
Neuropsychopharmacology; 2003 Sep; 28(9):1703-11. PubMed ID: 12813475
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man.
Karlsson P; Sedvall G; Halldin C; Swahn CG; Farde L
Psychopharmacology (Berl); 1995 Oct; 121(3):300-8. PubMed ID: 8584610
[TBL] [Abstract][Full Text] [Related]
11. Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET.
Rosa-Neto P; Doudet DJ; Cumming P
Neuroimage; 2004 Jul; 22(3):1076-83. PubMed ID: 15219579
[TBL] [Abstract][Full Text] [Related]
12. Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility.
Abi-Dargham A; Martinez D; Mawlawi O; Simpson N; Hwang DR; Slifstein M; Anjilvel S; Pidcock J; Guo NN; Lombardo I; Mann JJ; Van Heertum R; Foged C; Halldin C; Laruelle M
J Cereb Blood Flow Metab; 2000 Feb; 20(2):225-43. PubMed ID: 10698059
[TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine D1 and D2 receptors in burning mouth syndrome.
Hagelberg N; Forssell H; Rinne JO; Scheinin H; Taiminen T; Aalto S; Luutonen S; Någren K; Jääskeläinen S
Pain; 2003 Jan; 101(1-2):149-54. PubMed ID: 12507709
[TBL] [Abstract][Full Text] [Related]
14. A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain.
Chou YH; Karlsson P; Halldin C; Olsson H; Farde L
Psychopharmacology (Berl); 1999 Sep; 146(2):220-7. PubMed ID: 10525759
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
Lublin H; Gerlach J; Mørkeberg F
Psychopharmacology (Berl); 1994 Apr; 114(3):495-504. PubMed ID: 7855208
[TBL] [Abstract][Full Text] [Related]
16. Altered dopamine D2 receptor binding in atypical facial pain.
Hagelberg N; Forssell H; Aalto S; Rinne JO; Scheinin H; Taiminen T; Någren K; Eskola O; Jääskeläinen SK
Pain; 2003 Nov; 106(1-2):43-8. PubMed ID: 14581109
[TBL] [Abstract][Full Text] [Related]
17. Clozapine binds preferentially to cortical D1-like dopamine receptors in the primate brain: a PET study.
Chou YH; Halldin C; Farde L
Psychopharmacology (Berl); 2006 Mar; 185(1):29-35. PubMed ID: 16395606
[TBL] [Abstract][Full Text] [Related]
18. Measurement of cortical dopamine d1 receptor binding with 11C[SCH23390]: a test-retest analysis.
Hirvonen J; Någren K; Kajander J; Hietala J
J Cereb Blood Flow Metab; 2001 Oct; 21(10):1146-50. PubMed ID: 11598491
[TBL] [Abstract][Full Text] [Related]
19. Effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the dopaminergic and cholinergic receptors as evaluated by positron emission tomography in the Rhesus monkey.
Tani Y; Ishihara T; Kanai T; Ohno T; Andersson J; Lilja A; Antoni G; Fasth KJ; Bjurling P; Westerberg G
J Neural Transm Gen Sect; 1995; 102(3):189-208. PubMed ID: 8788068
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists.
Nielsen EB; Andersen PH
Eur J Pharmacol; 1992 Aug; 219(1):35-44. PubMed ID: 1397048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
